OPEN Healthcare Inc., (“OHC”) operates a next-generation clinical laboratory specializing in molecular diagnostics (MDx). We have created a rapid-deployment diagnostic platform focused on quickly delivering a broad and diverse test menu to the US market.

Our primary competitive advantage is a strategic partnership with Seegene, the global leader in multiplex MDx technology. By leveraging their deep content pipeline and utilizing the Laboratory Developed Test (LDT) pathway, we can launch complex, high-impact molecular tests with unprecedented speed and capital efficiency.